Deleted in Liver Cancer 2 (DLC2) protein expression in hepatocellular carcinoma
Dominika Wolosz1, Agnieszka Walczak, Grzegorz Szparecki
1Medical University of Warsaw, Department of Pathology. domi.wolosz@gmail.com.
Abstract:
Deleted in Liver Cancer (DLC) proteins belong to the family of RhoGAPs and are believed to operate as negative regulators of the Rho family of small GTPases. So far, the role of the first identified member from the DLC family, DLC1, was established as a tumor suppressor in hepatocellular carcinoma. The function of its close family relative, DLC2 is unequivocal. In the present study we attempted to determine whether the loss of DLC2 is a common feature of hepatocellular carcinoma tissue. We examined two types of hepatocellular carcinoma- typical and fibrolamellar one. Our analysis revealed that DLC2 protein is not diminished in cancer tissue when compared to non-cancerous liver specimens. What is more, we observed DLC2 to be more abundantly expressed in cancer tissue, particularly in tumors with the inflammation background. In addition, we found that DLC2 gene status was diploid in virtually all tumor samples examined. Our results indicate that DLC2 is not diminished in hepatocellular carcinoma cells. It appears that members of the DLC family, although structurally highly related, may function differently in cancer cells.
Insights
Deleted in Liver Cancer 2 (DLC2) protein is not diminished in hepatocellular carcinoma. Instead, DLC2 is more abundant in tumors, suggesting different roles for DLC family members in cancer.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Deleted in Liver Cancer (DLC) proteins are RhoGAP family members, negatively regulating Rho GTPases.
- DLC1 is a known tumor suppressor in hepatocellular carcinoma (HCC).
- The role of DLC2 in HCC remains unclear.
Purpose of the Study:
- To investigate if DLC2 protein levels are reduced in hepatocellular carcinoma tissue.
- To determine the gene status of DLC2 in HCC samples.
Main Methods:
- Analysis of DLC2 protein expression in typical and fibrolamellar HCC tissues compared to non-cancerous liver specimens.
- Assessment of DLC2 gene copy number in tumor samples.
Main Results:
- DLC2 protein is not diminished in HCC tissue; it is often more abundant, especially in tumors with inflammation.
- DLC2 gene status is diploid in most examined tumor samples.
- DLC1 and DLC2 may have distinct functions in cancer despite structural similarities.
Conclusions:
- DLC2 is not downregulated in hepatocellular carcinoma.
- DLC2 expression is elevated in some HCC, particularly those with inflammatory components.
- DLC family members exhibit differential roles in cancer progression.
Related Concept Videos
Chromatin Position Affects Gene Expression
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the...
Cell Specific Gene Expression
What is Gene Expression?
Gene expression is the process in which DNA directs the synthesis of functional products, that is, proteins. Cells can regulate gene expression at various stages. It allows organisms to generate different cell types and enables cells to adapt to internal and external factors.
Genetic Information Flows from DNA to RNA to Protein
A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is made up of nucleotides and proteins consist of amino...
Liver Histology
Hepatocytes perform a variety of essential functions. They secrete...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...


